Smith & Nephew (LON:SN) Price Target Lowered to GBX 1,243 at JPMorgan Chase & Co.

Smith & Nephew (LON:SNGet Rating) had its price objective reduced by equities researchers at JPMorgan Chase & Co. from GBX 1,442 ($17.67) to GBX 1,243 ($15.23) in a report released on Thursday, reports. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target suggests a potential upside of 16.11% from the company’s current price.

SN has been the subject of a number of other reports. Credit Suisse Group cut their price target on Smith & Nephew from GBX 1,540 ($18.87) to GBX 1,400 ($17.15) and set an “outperform” rating for the company in a report on Thursday. Royal Bank of Canada reaffirmed an “outperform” rating and issued a GBX 1,700 ($20.83) price target on shares of Smith & Nephew in a report on Thursday, July 21st. Berenberg Bank cut their price target on Smith & Nephew from GBX 1,825 ($22.36) to GBX 1,490 ($18.26) and set a “buy” rating for the company in a report on Tuesday, July 26th. Finally, Barclays cut their price target on Smith & Nephew from GBX 1,630 ($19.97) to GBX 1,550 ($18.99) and set an “overweight” rating for the company in a report on Thursday. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from, Smith & Nephew has an average rating of “Moderate Buy” and an average target price of GBX 1,476.60 ($18.09).

Smith & Nephew Stock Down 0.9 %

Shares of LON SN opened at GBX 1,070.50 ($13.12) on Thursday. The business has a fifty day moving average of GBX 1,168.33 and a two-hundred day moving average of GBX 1,221.05. The company has a debt-to-equity ratio of 53.62, a quick ratio of 0.84 and a current ratio of 1.78. Smith & Nephew has a 52-week low of GBX 1,002 ($12.28) and a 52-week high of GBX 1,440.89 ($17.66). The stock has a market cap of £9.34 billion and a PE ratio of 2,298.94.

Insiders Place Their Bets

In other news, insider Deepak Nath sold 26,529 shares of the business’s stock in a transaction dated Monday, May 16th. The stock was sold at an average price of GBX 1,278 ($15.66), for a total transaction of £339,040.62 ($415,440.04).

About Smith & Nephew

(Get Rating)

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures.

Read More

Analyst Recommendations for Smith & Nephew (LON:SN)

Want More Great Investing Ideas?

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with's FREE daily email newsletter.